J. Girard et al., AZELASTINE PROTECTS AGAINST CA1 TRAUMATIC NEURONAL INJURY IN THE HIPPOCAMPAL SLICE, European journal of pharmacology, 300(1-2), 1996, pp. 43-49
Activation of NMDA receptors appears to play a important role in traum
atic neuronal injury. Additionally, N-methyl-D-aspartate (NMDA) excito
toxicity may involve leukotriene production. Therefore, we investigate
d whether azelastine, an anti-allergic agent inhibiting the synthesis
and release of leukotrienes, could protect against CA1 traumatic neuro
nal injury in the hippocampal slice. Fluid percussion trauma produced
evidence of severe neuronal injury with CA1 antidromic population spik
e amplitude recovering after 95 min to only a mean 16 +/- 1% S.E. of i
nitial amplitude. With 15 mu M azelastine treatment given after trauma
for 35 min this recovery improved to 112 +/- 17%. The azelastine EC(5
0) for this protection was 10 mu M Significant protection was also see
n with azelastine application begun 15 min after trauma. Azelastine al
so protected the ability to induce long-term potentiation after trauma
. The specific leukotriene inhibitors, MK-571 and MK-886, similarly pr
ovided significant neuroprotection. These findings suggest that CAI tr
aumatic neuronal injury may be mediated by leukotriene production.